| 图片 | 名称及描述 | |
|---|---|---|
|
G2F 2AB
97%
|
||
|
G2 2AB (500pmol/vial)
97%
|
||
|
Gitoxin
97%
|
||
|
GT 949
98%
|
||
|
Glycine, N-[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]-N-methyl-, compd. with cyclohexanamine (1:1)
Glycine, N-[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]-N-methyl-, compd. with cyclohexanamine (1:1)
97%
|
||
|
Golimumab
97%
|
||
|
GSK3-IN-1
97%
|
||
|
GSK3β inhibitor II
97%
|
||
|
Guanosine 5'-diphosphate sodium salt
97%
|
||
|
Globotriose
97%
|
||
|
GLP-1R Antagonist 1
97%
|
||
|
Guanosine 5'-(trihydrogen diphosphate), P'-b-L-galactopyranosyl ester
97%
|
||
|
Ggti-2418
97%
|
||
|
GDP366
97%
|
||
|
GPR41 agonist-1
97%
|
||
|
Gibberellin A7
97%
|
||
|
GW-803430
98%
|
||
|
Glucosylsphingosine
97%
|
||
|
GSK-3β inhibitor 11
97%
|
||
|
Glycine, N-3-butenyl-N-[(1R)-1-phenylethyl]-, ethyl ester
97%
|

